Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood-Brain Barrier | 15 | 2019 | 43 | 3.350 |
Why?
|
| Brain | 24 | 2021 | 1689 | 2.060 |
Why?
|
| Brain Injuries | 7 | 2019 | 47 | 2.000 |
Why?
|
| Alzheimer Disease | 15 | 2023 | 1942 | 1.990 |
Why?
|
| TDP-43 Proteinopathies | 6 | 2023 | 104 | 1.920 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2023 | 22 | 1.790 |
Why?
|
| Lewy Bodies | 8 | 2023 | 195 | 1.720 |
Why?
|
| Aging | 17 | 2023 | 1593 | 1.720 |
Why?
|
| Frontotemporal Lobar Degeneration | 3 | 2023 | 28 | 1.710 |
Why?
|
| DNA-Binding Proteins | 8 | 2023 | 254 | 1.590 |
Why?
|
| Olfaction Disorders | 2 | 2021 | 53 | 1.460 |
Why?
|
| Frontotemporal Dementia | 3 | 2023 | 14 | 1.210 |
Why?
|
| Aged, 80 and over | 31 | 2023 | 4851 | 1.090 |
Why?
|
| Angiopoietin-1 | 6 | 2016 | 6 | 1.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2019 | 65 | 1.080 |
Why?
|
| Cerebral Cortex | 5 | 2021 | 195 | 1.070 |
Why?
|
| Lewy Body Disease | 3 | 2021 | 98 | 1.020 |
Why?
|
| Male | 44 | 2023 | 15621 | 0.930 |
Why?
|
| Rats | 15 | 2019 | 854 | 0.910 |
Why?
|
| Cognitive Dysfunction | 5 | 2023 | 938 | 0.890 |
Why?
|
| Dementia | 5 | 2019 | 521 | 0.870 |
Why?
|
| Brain Edema | 5 | 2011 | 22 | 0.870 |
Why?
|
| Substantia Nigra | 3 | 2021 | 148 | 0.860 |
Why?
|
| Animals | 22 | 2019 | 4552 | 0.860 |
Why?
|
| Parkinsonian Disorders | 6 | 2023 | 217 | 0.860 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 117 | 0.830 |
Why?
|
| Amygdala | 1 | 2021 | 50 | 0.790 |
Why?
|
| Humans | 56 | 2023 | 29337 | 0.780 |
Why?
|
| Endothelium, Vascular | 8 | 2005 | 61 | 0.780 |
Why?
|
| Olfactory Bulb | 2 | 2023 | 16 | 0.780 |
Why?
|
| Temporal Lobe | 2 | 2018 | 105 | 0.730 |
Why?
|
| Neocortex | 1 | 2019 | 34 | 0.710 |
Why?
|
| Immunohistochemistry | 7 | 2017 | 391 | 0.670 |
Why?
|
| Female | 38 | 2023 | 16197 | 0.660 |
Why?
|
| Angiopoietin-2 | 4 | 2005 | 4 | 0.660 |
Why?
|
| Longitudinal Studies | 9 | 2021 | 1442 | 0.650 |
Why?
|
| Caveolin 1 | 4 | 2016 | 9 | 0.630 |
Why?
|
| Pituitary Neoplasms | 1 | 2017 | 20 | 0.620 |
Why?
|
| Proteins | 2 | 2011 | 72 | 0.600 |
Why?
|
| Rats, Wistar | 8 | 2019 | 40 | 0.600 |
Why?
|
| Cognition | 7 | 2021 | 1277 | 0.590 |
Why?
|
| Neuroprotective Agents | 1 | 2016 | 59 | 0.550 |
Why?
|
| Cerebral Ventricle Neoplasms | 2 | 2013 | 5 | 0.540 |
Why?
|
| Glioma, Subependymal | 2 | 2013 | 5 | 0.540 |
Why?
|
| Memory Disorders | 1 | 2017 | 174 | 0.530 |
Why?
|
| Tight Junctions | 4 | 2011 | 28 | 0.520 |
Why?
|
| Neovascularization, Pathologic | 4 | 2005 | 56 | 0.520 |
Why?
|
| Spinal Cord | 4 | 2018 | 103 | 0.480 |
Why?
|
| Aged | 22 | 2023 | 9448 | 0.480 |
Why?
|
| Ependymoma | 1 | 2013 | 11 | 0.460 |
Why?
|
| Endothelial Cells | 2 | 2011 | 63 | 0.450 |
Why?
|
| Blood Vessels | 2 | 2011 | 16 | 0.450 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2023 | 115 | 0.450 |
Why?
|
| Hippocampus | 1 | 2015 | 274 | 0.450 |
Why?
|
| Cold Temperature | 4 | 2008 | 18 | 0.430 |
Why?
|
| Brain Diseases | 4 | 2021 | 82 | 0.430 |
Why?
|
| Fibronectins | 5 | 2019 | 29 | 0.430 |
Why?
|
| Autopsy | 5 | 2021 | 335 | 0.420 |
Why?
|
| Arteriolosclerosis | 3 | 2023 | 71 | 0.410 |
Why?
|
| Neuropsychological Tests | 7 | 2023 | 1251 | 0.390 |
Why?
|
| Parkinson Disease | 5 | 2023 | 1164 | 0.380 |
Why?
|
| Cell Adhesion Molecules | 2 | 2008 | 40 | 0.380 |
Why?
|
| Neurons | 5 | 2013 | 374 | 0.370 |
Why?
|
| RNA, Messenger | 4 | 2005 | 323 | 0.370 |
Why?
|
| Membrane Proteins | 2 | 2008 | 173 | 0.350 |
Why?
|
| Astrocytes | 1 | 2011 | 122 | 0.350 |
Why?
|
| Cognition Disorders | 5 | 2018 | 1011 | 0.340 |
Why?
|
| Disease Progression | 5 | 2019 | 787 | 0.340 |
Why?
|
| Microscopy, Electron | 3 | 2003 | 70 | 0.340 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 284 | 0.340 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 1113 | 0.330 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2007 | 5 | 0.320 |
Why?
|
| Mycosis Fungoides | 1 | 2007 | 6 | 0.320 |
Why?
|
| Horseradish Peroxidase | 4 | 2016 | 5 | 0.320 |
Why?
|
| Muscular Diseases | 1 | 2007 | 18 | 0.320 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2007 | 33 | 0.310 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 1221 | 0.310 |
Why?
|
| Occludin | 3 | 2016 | 13 | 0.310 |
Why?
|
| Cerebrovascular Disorders | 2 | 2023 | 132 | 0.300 |
Why?
|
| Spinal Cord Neoplasms | 2 | 2020 | 34 | 0.300 |
Why?
|
| Angiopoietins | 3 | 2011 | 15 | 0.280 |
Why?
|
| Depression | 3 | 2016 | 465 | 0.280 |
Why?
|
| Endothelial Growth Factors | 2 | 2002 | 6 | 0.280 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2005 | 1 | 0.260 |
Why?
|
| Pituitary Gland, Posterior | 1 | 2005 | 1 | 0.260 |
Why?
|
| Apoptosis | 2 | 2007 | 251 | 0.260 |
Why?
|
| Locus Coeruleus | 3 | 2013 | 23 | 0.260 |
Why?
|
| Disease Models, Animal | 4 | 2011 | 724 | 0.250 |
Why?
|
| Plaque, Amyloid | 2 | 2015 | 144 | 0.240 |
Why?
|
| Adult | 9 | 2023 | 8601 | 0.240 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2003 | 4 | 0.240 |
Why?
|
| Limbic Encephalitis | 1 | 2023 | 10 | 0.230 |
Why?
|
| Caveolae | 3 | 2011 | 18 | 0.230 |
Why?
|
| Independent Living | 3 | 2023 | 281 | 0.230 |
Why?
|
| Neovascularization, Physiologic | 2 | 2019 | 22 | 0.230 |
Why?
|
| Motor Disorders | 1 | 2023 | 22 | 0.230 |
Why?
|
| Neurofibrillary Tangles | 4 | 2023 | 181 | 0.230 |
Why?
|
| Histocytochemistry | 1 | 2003 | 26 | 0.230 |
Why?
|
| Cerebrum | 1 | 2023 | 9 | 0.230 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 101 | 0.230 |
Why?
|
| Cohort Studies | 6 | 2018 | 1939 | 0.220 |
Why?
|
| Atherosclerosis | 1 | 2023 | 72 | 0.220 |
Why?
|
| Meningitis | 1 | 2022 | 11 | 0.220 |
Why?
|
| Telencephalon | 1 | 2002 | 2 | 0.210 |
Why?
|
| Amyloid beta-Peptides | 3 | 2023 | 294 | 0.200 |
Why?
|
| Signal Transduction | 2 | 2016 | 482 | 0.200 |
Why?
|
| Logistic Models | 3 | 2017 | 407 | 0.200 |
Why?
|
| Rhabdoid Tumor | 1 | 2020 | 3 | 0.190 |
Why?
|
| Late Onset Disorders | 1 | 2020 | 6 | 0.190 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 13 | 0.190 |
Why?
|
| Rats, Inbred WF | 3 | 2005 | 6 | 0.180 |
Why?
|
| Illinois | 1 | 2020 | 241 | 0.180 |
Why?
|
| Coloring Agents | 2 | 2013 | 13 | 0.170 |
Why?
|
| Capillary Permeability | 3 | 2003 | 26 | 0.170 |
Why?
|
| Motor Neurons | 1 | 2018 | 21 | 0.170 |
Why?
|
| Headache | 2 | 2017 | 43 | 0.170 |
Why?
|
| Comorbidity | 1 | 2020 | 498 | 0.170 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 116 | 0.160 |
Why?
|
| Middle Aged | 9 | 2019 | 9823 | 0.160 |
Why?
|
| Movement | 1 | 2018 | 143 | 0.160 |
Why?
|
| Facial Pain | 1 | 2017 | 5 | 0.160 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2017 | 3 | 0.160 |
Why?
|
| Age Factors | 1 | 2020 | 843 | 0.160 |
Why?
|
| Vision Disorders | 1 | 2017 | 23 | 0.160 |
Why?
|
| Microvessels | 1 | 2017 | 16 | 0.160 |
Why?
|
| Brain Infarction | 1 | 2018 | 74 | 0.160 |
Why?
|
| Phosphorylation | 2 | 2016 | 159 | 0.160 |
Why?
|
| Linear Models | 1 | 2018 | 254 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2011 | 9 | 0.150 |
Why?
|
| Fluorescent Dyes | 2 | 2011 | 54 | 0.150 |
Why?
|
| Fragile X Syndrome | 1 | 2020 | 189 | 0.150 |
Why?
|
| Endothelium | 2 | 2011 | 12 | 0.150 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 14 | 0.150 |
Why?
|
| Brain Stem | 2 | 2016 | 25 | 0.150 |
Why?
|
| Time Factors | 4 | 2013 | 1616 | 0.150 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 113 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor B | 2 | 2009 | 2 | 0.140 |
Why?
|
| Hypertension | 3 | 2003 | 266 | 0.140 |
Why?
|
| Epidermal Cyst | 1 | 2016 | 6 | 0.140 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 389 | 0.140 |
Why?
|
| Brain Chemistry | 1 | 2016 | 47 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 56 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 145 | 0.140 |
Why?
|
| Central Nervous System Cysts | 1 | 2015 | 6 | 0.130 |
Why?
|
| Choroid Plexus | 2 | 2007 | 7 | 0.130 |
Why?
|
| Visceral Afferents | 1 | 2015 | 4 | 0.130 |
Why?
|
| Sphenoid Sinus | 1 | 2015 | 15 | 0.130 |
Why?
|
| Spinal Cord Dorsal Horn | 1 | 2015 | 8 | 0.130 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 65 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2015 | 24 | 0.130 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 107 | 0.130 |
Why?
|
| Sclerosis | 1 | 2015 | 68 | 0.130 |
Why?
|
| Cell Membrane | 2 | 2007 | 105 | 0.130 |
Why?
|
| Multiple System Atrophy | 1 | 2015 | 42 | 0.130 |
Why?
|
| Skull Base Neoplasms | 1 | 2014 | 15 | 0.130 |
Why?
|
| United States | 1 | 2021 | 2333 | 0.130 |
Why?
|
| Pineal Gland | 1 | 2014 | 3 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 2 | 2005 | 40 | 0.120 |
Why?
|
| gamma-Tocopherol | 1 | 2014 | 7 | 0.120 |
Why?
|
| alpha-Tocopherol | 1 | 2014 | 9 | 0.120 |
Why?
|
| Immunocompetence | 1 | 2013 | 6 | 0.120 |
Why?
|
| Neuroma, Acoustic | 1 | 2013 | 10 | 0.120 |
Why?
|
| Quadriplegia | 1 | 2013 | 8 | 0.120 |
Why?
|
| Coccidioidomycosis | 1 | 2013 | 7 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2013 | 10 | 0.120 |
Why?
|
| Mesencephalon | 1 | 2013 | 44 | 0.120 |
Why?
|
| Apolipoprotein E4 | 1 | 2015 | 227 | 0.120 |
Why?
|
| Radiosurgery | 1 | 2013 | 33 | 0.120 |
Why?
|
| alpha-Synuclein | 1 | 2015 | 138 | 0.120 |
Why?
|
| Ki-67 Antigen | 1 | 2013 | 13 | 0.120 |
Why?
|
| Leiomyosarcoma | 1 | 2013 | 7 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2013 | 8 | 0.120 |
Why?
|
| Psychomotor Disorders | 1 | 2013 | 10 | 0.110 |
Why?
|
| Biomarkers | 2 | 2007 | 689 | 0.110 |
Why?
|
| Inflammation | 3 | 2007 | 344 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2013 | 48 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 124 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 1830 | 0.100 |
Why?
|
| Neurosurgical Procedures | 1 | 2013 | 150 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2011 | 20 | 0.100 |
Why?
|
| Antibodies | 1 | 2011 | 65 | 0.100 |
Why?
|
| Synapses | 1 | 2011 | 50 | 0.100 |
Why?
|
| Aquaporin 1 | 1 | 2009 | 1 | 0.090 |
Why?
|
| Aquaporin 4 | 1 | 2009 | 6 | 0.090 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 22 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2019 | 1811 | 0.090 |
Why?
|
| Junctional Adhesion Molecules | 1 | 2008 | 1 | 0.080 |
Why?
|
| Receptor, TIE-2 | 2 | 2005 | 2 | 0.080 |
Why?
|
| Sural Nerve | 1 | 2007 | 4 | 0.080 |
Why?
|
| Neural Conduction | 1 | 2007 | 8 | 0.080 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 20 | 0.080 |
Why?
|
| Claudin-5 | 1 | 2007 | 3 | 0.080 |
Why?
|
| Muscle Weakness | 1 | 2007 | 32 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2014 | 343 | 0.080 |
Why?
|
| Alleles | 2 | 2020 | 224 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2007 | 30 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2007 | 112 | 0.080 |
Why?
|
| Skin | 1 | 2007 | 117 | 0.080 |
Why?
|
| Biopsy | 1 | 2007 | 234 | 0.070 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2007 | 5 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 211 | 0.070 |
Why?
|
| Calcium | 1 | 2011 | 491 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2007 | 174 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 16 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2005 | 30 | 0.070 |
Why?
|
| Caspases | 1 | 2005 | 32 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2005 | 6 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 145 | 0.060 |
Why?
|
| Prognosis | 1 | 2007 | 840 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 349 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2013 | 3478 | 0.060 |
Why?
|
| Gene Expression | 1 | 2005 | 226 | 0.060 |
Why?
|
| Memory | 2 | 2018 | 318 | 0.060 |
Why?
|
| Myocardium | 1 | 2004 | 139 | 0.060 |
Why?
|
| Encephalitis | 1 | 2003 | 17 | 0.060 |
Why?
|
| Infarction | 1 | 2023 | 23 | 0.060 |
Why?
|
| CpG Islands | 1 | 2003 | 34 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 172 | 0.060 |
Why?
|
| Microtomy | 1 | 2003 | 1 | 0.060 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 2003 | 1 | 0.060 |
Why?
|
| Lanthanum | 1 | 2003 | 2 | 0.060 |
Why?
|
| Monosaccharides | 1 | 2003 | 2 | 0.060 |
Why?
|
| Tissue Embedding | 1 | 2003 | 5 | 0.060 |
Why?
|
| Cell Count | 2 | 2013 | 99 | 0.060 |
Why?
|
| Pia Mater | 1 | 2003 | 5 | 0.060 |
Why?
|
| Pericytes | 1 | 2003 | 4 | 0.060 |
Why?
|
| Tissue Fixation | 1 | 2003 | 10 | 0.060 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2003 | 6 | 0.060 |
Why?
|
| Peroxidases | 1 | 2003 | 7 | 0.060 |
Why?
|
| Staining and Labeling | 1 | 2003 | 22 | 0.060 |
Why?
|
| Basement Membrane | 1 | 2003 | 12 | 0.060 |
Why?
|
| Capillaries | 1 | 2003 | 11 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2003 | 21 | 0.060 |
Why?
|
| Antigens | 1 | 2003 | 26 | 0.060 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2003 | 22 | 0.060 |
Why?
|
| Vasoconstriction | 1 | 2003 | 24 | 0.060 |
Why?
|
| Chemokines | 1 | 2003 | 29 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2003 | 31 | 0.060 |
Why?
|
| Cats | 1 | 2003 | 76 | 0.060 |
Why?
|
| Mitotic Index | 1 | 2002 | 4 | 0.060 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 6 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2003 | 129 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 46 | 0.060 |
Why?
|
| Mitochondria | 1 | 2003 | 78 | 0.050 |
Why?
|
| Meninges | 1 | 2022 | 6 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2022 | 19 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2003 | 189 | 0.050 |
Why?
|
| Lymphokines | 1 | 2002 | 9 | 0.050 |
Why?
|
| Macrophages | 1 | 2003 | 128 | 0.050 |
Why?
|
| tau Proteins | 1 | 2023 | 202 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 129 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 129 | 0.050 |
Why?
|
| Mice | 2 | 2003 | 1607 | 0.050 |
Why?
|
| Lumbar Vertebrae | 2 | 2018 | 487 | 0.050 |
Why?
|
| Cranial Fossa, Posterior | 2 | 2014 | 7 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2003 | 172 | 0.050 |
Why?
|
| Models, Biological | 1 | 2003 | 343 | 0.050 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2020 | 47 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2020 | 117 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2020 | 141 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 642 | 0.040 |
Why?
|
| Young Adult | 2 | 2015 | 1932 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2019 | 136 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3273 | 0.040 |
Why?
|
| Microglia | 1 | 2018 | 124 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2018 | 132 | 0.040 |
Why?
|
| Scalp | 1 | 2016 | 6 | 0.040 |
Why?
|
| Sacrum | 1 | 2015 | 27 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 86 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 103 | 0.030 |
Why?
|
| Cell Nucleus Shape | 1 | 2014 | 2 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 8 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 405 | 0.030 |
Why?
|
| Raphe Nuclei | 1 | 2013 | 8 | 0.030 |
Why?
|
| Ventral Tegmental Area | 1 | 2013 | 12 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 111 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2012 | 34 | 0.030 |
Why?
|
| Amyloid | 1 | 2012 | 53 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 531 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2014 | 604 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2012 | 298 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2013 | 349 | 0.020 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2007 | 1 | 0.020 |
Why?
|
| CD59 Antigens | 1 | 2007 | 3 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 15 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2007 | 8 | 0.020 |
Why?
|
| Epithelium | 1 | 2007 | 26 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 55 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2007 | 64 | 0.020 |
Why?
|
| Necrosis | 1 | 2005 | 26 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 215 | 0.020 |
Why?
|
| Craniotomy | 1 | 2005 | 23 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2004 | 28 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2004 | 170 | 0.020 |
Why?
|
| Gene Library | 1 | 2003 | 9 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2003 | 55 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 31 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 32 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 451 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2003 | 140 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 156 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 403 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 676 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 495 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 2279 | 0.010 |
Why?
|